Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice

Area of Science:

• Immunology
• Cardiovascular Research
• Atherosclerosis Pathogenesis

Background:

• Interferon-gamma (IFN-gamma) has been implicated in the development of atherosclerosis.
• The precise role of exogenous IFN-gamma in atherogenesis remains to be fully elucidated.
• Understanding immune system involvement is crucial for cardiovascular disease research.

Purpose of the Study:

• To investigate the direct effect of administered interferon-gamma on atherosclerosis progression.
• To determine if IFN-gamma influences lesion size and immune cell composition in susceptible mice.
• To evaluate the relationship between IFN-gamma, cholesterol levels, and atherosclerotic plaque development.

Main Methods:

• Administration of recombinant IFN-gamma or phosphate-buffered saline to apolipoprotein E-deficient mice for 30 days.
• Quantification of atherosclerotic lesion size in the ascending aorta.
• Analysis of T lymphocyte and major histocompatibility complex (MHC) class II-positive cell infiltration within lesions.

Main Results:

• IFN-gamma administration led to a significant twofold increase in atherosclerotic lesion size.
• Despite a 15% reduction in serum cholesterol, IFN-gamma significantly elevated T lymphocyte and MHC class II-positive cell counts within lesions.
• These findings were observed in atherosclerosis-susceptible apolipoprotein E-/- mice on a normal diet.

Conclusions:

• Exogenous interferon-gamma administration promotes atherosclerosis development.
• IFN-gamma exacerbates atherogenesis independently of its cholesterol-lowering effects.
• The study supports a pro-atherogenic role for IFN-gamma in the context of cardiovascular disease.